Insmed (INSM) Exchange Rate Effect (2016 - 2026)
Insmed (INSM) recorded quarterly Exchange Rate Effect of -$553000.0 in Q1 2026, down 8000.0% quarter-over-quarter from $7000.0 in Q4 2025, and down 161.79% on a YoY basis from $895000.0 in Q1 2025.
Insmed (INSM) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Insmed's Exchange Rate Effect history runs 11 years deep, the most recent figure standing at -$553000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 161.79% year-over-year to -$553000.0; the TTM figure through Mar 2026 stood at -$517000.0 (down 195.56% YoY), while the FY2025 annual figure was $931000.0, up 171.23% from the prior year.
- Exchange Rate Effect was -$553000.0 for Q1 2026 at Insmed, down from $7000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.2 million in Q3 2023 to a low of -$3.4 million in Q2 2023.
- Historically, Exchange Rate Effect has averaged -$127941.2 across 5 years, with a median of -$553000.0 in 2026.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect soared 501.08% in 2022, then slumped 3186.21% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$1.1 million in 2022, then surged by 188.64% to $1.0 million in 2023, then plunged by 248.42% to -$1.5 million in 2024, then soared by 100.47% to $7000.0 in 2025, then sank by 8000.0% to -$553000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$553000.0 (Q1 2026), $7000.0 (Q4 2025), and -$976000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -553,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -553,000.00 |
| Mar 31, 2026 | -553,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | -976,000.00 |
| Sep 30, 2025 | -976,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 895,000.00 |
| Mar 31, 2025 | 895,000.00 |
| Dec 31, 2024 | -1.51 Mn |
| Dec 31, 2024 | -1.51 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | -688,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Dec 31, 2023 | 1.01 Mn |